Drug Profile
Propranolol - Pierre Fabre
Alternative Names: Beta-blocker- Pierre-Fabre; Hemangeol; Hemangiol; M7030; M703101; Propanerol; Propranolol- Pierre-FabreLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator University of Bordeaux
- Developer Maruho; Pierre Fabre
- Class Antihypertensives; Antimigraines; Class II antiarrhythmics; Ischaemic heart disorder therapies; Naphthalenes; Propanolamines; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemangioma
Most Recent Events
- 23 Feb 2021 Discontinued - Phase-II for Haemangioma in France (Topical, Gel)
- 23 Feb 2021 Discontinued - Phase-II for Haemangioma in Poland (Topical, Gel)
- 23 Feb 2021 Discontinued - Phase-II for Haemangioma in Spain (Topical, Gel)